The article presents a generalization of the available information on the course of digestive diseases, based on literary data and many years of personal experience of doctor Yuliya Ivanovna Korshikova, PhD Candidate in Medicine, in treating patients by means of herbal medicine.
{"title":"Herbal medicine for digestive diseases","authors":"Yu. I. Korshikova","doi":"10.33920/med-03-2311-03","DOIUrl":"https://doi.org/10.33920/med-03-2311-03","url":null,"abstract":"The article presents a generalization of the available information on the course of digestive diseases, based on literary data and many years of personal experience of doctor Yuliya Ivanovna Korshikova, PhD Candidate in Medicine, in treating patients by means of herbal medicine.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"101 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139247086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. D. Alekseeva, I. I. Sirotko, G. R. Bulkhina, R. I. Bulkhin
The article presents data on the implementation of the federal project «Development of the export of medical services» in terms of the implementation of recommendations on the maintenance of websites of medical organizations with the reflection of information for foreign citizens wishing to receive elective care in the Russian Federation. The analysis of the websites of medical organizations of the Samara Region and the neighboring Ulyanovsk Region was carried out in order to study the availability of information that could interest a potential patient to make a decision about hospitalization or receiving other medical care in this particular medical organization. Taking into account the analysis, the prospects for the implementation of the federal project at the regional level are determined
{"title":"Assessment of the promotion of export of medical services in the Samara Region through websites of medical organizations","authors":"N. D. Alekseeva, I. I. Sirotko, G. R. Bulkhina, R. I. Bulkhin","doi":"10.33920/med-03-2311-01","DOIUrl":"https://doi.org/10.33920/med-03-2311-01","url":null,"abstract":"The article presents data on the implementation of the federal project «Development of the export of medical services» in terms of the implementation of recommendations on the maintenance of websites of medical organizations with the reflection of information for foreign citizens wishing to receive elective care in the Russian Federation. The analysis of the websites of medical organizations of the Samara Region and the neighboring Ulyanovsk Region was carried out in order to study the availability of information that could interest a potential patient to make a decision about hospitalization or receiving other medical care in this particular medical organization. Taking into account the analysis, the prospects for the implementation of the federal project at the regional level are determined","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"33 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139247270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Currently, medical organizations are increasingly faced with the inappropriate use of funds of compulsory medical insurance and, as a result, with a significant number of court precedents on this basis. Despite the fact that legal documents regulate in sufficient detail the limit for the targeted use of compulsory medical insurance funds, controversial issues, both on the part of medical organizations and relevant regulatory authorities, often arise.Within the framework of this article, we will analyze the judicial precedents of the misuse of compulsory medical insurance funds and try to identify the main predictable causes of the misuse.
{"title":"Trends in judicial practice on the payment of medical care within compulsory medical insurance","authors":"V. I. Smirnova, T. Romanova","doi":"10.33920/med-03-2311-02","DOIUrl":"https://doi.org/10.33920/med-03-2311-02","url":null,"abstract":"Currently, medical organizations are increasingly faced with the inappropriate use of funds of compulsory medical insurance and, as a result, with a significant number of court precedents on this basis. Despite the fact that legal documents regulate in sufficient detail the limit for the targeted use of compulsory medical insurance funds, controversial issues, both on the part of medical organizations and relevant regulatory authorities, often arise.Within the framework of this article, we will analyze the judicial precedents of the misuse of compulsory medical insurance funds and try to identify the main predictable causes of the misuse.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"41 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139250582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The aim of the study is to research the possibilities of developing an intelligent drug search system. In order to do this, the statutes and regulations in the field of circulation of medicines in the Russian Federation have been studied; a comparative analysis of the search capabilities of popular digital services for the sale of medicines has been carried out. The object of the study is a system of drug search through digital services. The subject of study is the features of the functioning of systems of drug search through digital services. According to the authors’ hypothesis, the introduction of an intelligent drug search system will allow improving the search for certified drugs and enhancing user experience.
{"title":"Theoretical and methodological review of the modern drug market","authors":"Т. Shakhovskiy, N. Vyatkina","doi":"10.33920/med-03-2308-02","DOIUrl":"https://doi.org/10.33920/med-03-2308-02","url":null,"abstract":"The aim of the study is to research the possibilities of developing an intelligent drug search system. In order to do this, the statutes and regulations in the field of circulation of medicines in the Russian Federation have been studied; a comparative analysis of the search capabilities of popular digital services for the sale of medicines has been carried out. The object of the study is a system of drug search through digital services. The subject of study is the features of the functioning of systems of drug search through digital services. According to the authors’ hypothesis, the introduction of an intelligent drug search system will allow improving the search for certified drugs and enhancing user experience.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126426098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The main goal of the study was to determine the effectiveness of surgical treatment of solitary and multiple hemangiomas within the vertebral body of the thoracic and lumbar spine.
该研究的主要目的是确定手术治疗胸椎和腰椎椎体内单发和多发血管瘤的有效性。
{"title":"Results of surgical treatment of patients with hemangiomas of the thoracic and lumbar vertebrae","authors":"A. A. Baratov, D. Ruzibaev","doi":"10.33920/med-03-2308-03","DOIUrl":"https://doi.org/10.33920/med-03-2308-03","url":null,"abstract":"The main goal of the study was to determine the effectiveness of surgical treatment of solitary and multiple hemangiomas within the vertebral body of the thoracic and lumbar spine.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"368 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134326622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The paper studies the regional features of the creation and functioning of the site of a private medical organization with the introduction of an administration system, using the case of the company OOO «El-Med» (Vologda).
{"title":"Study of regional features of the creation and functioning of the site of a private medical organization with the introduction of an administration system","authors":"I. E. Utkin, N. Vyatkina","doi":"10.33920/med-03-2308-01","DOIUrl":"https://doi.org/10.33920/med-03-2308-01","url":null,"abstract":"The paper studies the regional features of the creation and functioning of the site of a private medical organization with the introduction of an administration system, using the case of the company OOO «El-Med» (Vologda).","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132318377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cardiovascular diseases are a common cause of death throughout the world, and in Russia this figure reaches high values as well. The main cause of cardiovascular pathologies is atherosclerosis, which develops against the background of lipid metabolism disorders, in particular, the accumulation of low-density lipoprotein cholesterol. Statins are the main drug in the complex therapy of dyslipidemia, however, their limited use in patients with diagnosed diabetes mellitus and statin intolerance reduces the possibilities and effectiveness of adequate long-term therapy for hyperlipidemia. PCSK9 inhibitors are promising drugs in terms of efficacy, nevertheless, the question of the possibility of using these drugs in patient groups with statin limitations arises. The purpose of the review. This article provides information on the use of PCSK9 inhibitors in the largest populations with limitations to statin therapy (patients with diabetes mellitus and patients with statin intolerance). We identified potentially relevant studies by searching the electronic databases MEDLINE, SCOPUS, PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews over the last 5 years up to March 2023 using the terms: dyslipidemia, hyperlipidemia, atherosclerosis, PCSK9 inhibitor, statins, low-density lipoproteins, cholesterol, efficacy, safety, therapy. Further, according to the inclusion and exclusion criteria, as well as independent selection, all authors of this article selected the sources that met the criteria and compiled this review. Results. PCSK9 inhibitors are generally a safe, well tolerated, and effective therapeutic strategy with an established role in the therapeutic treatment of hyperlipidemias. Theoretically, PCSK9 inhibitors can be used as an alternative to statin therapy for groups of patients with statin intolerance and those with diagnosed diabetes mellitus, as well as in risk groups. As the experience with using PCSK9 inhibitors in the Russian Federation is growing rapidly, future trials are expected to shed light on their long-term safety and tolerability. On the other hand, other potential therapeutic strategies targeting PCSK9 are being developed, including inclisiran, already registered in the Russian Federation, which is also promising in the treatment of lipid metabolism disorders.
{"title":"Feasibility and efficacy of PCSK9 inhibitors in cases of statin therapy limitation or intolerance","authors":"K. O. Shnaider, V. A. Baranova, M. Maksimov","doi":"10.33920/med-03-2307-02","DOIUrl":"https://doi.org/10.33920/med-03-2307-02","url":null,"abstract":"Cardiovascular diseases are a common cause of death throughout the world, and in Russia this figure reaches high values as well. The main cause of cardiovascular pathologies is atherosclerosis, which develops against the background of lipid metabolism disorders, in particular, the accumulation of low-density lipoprotein cholesterol. Statins are the main drug in the complex therapy of dyslipidemia, however, their limited use in patients with diagnosed diabetes mellitus and statin intolerance reduces the possibilities and effectiveness of adequate long-term therapy for hyperlipidemia. PCSK9 inhibitors are promising drugs in terms of efficacy, nevertheless, the question of the possibility of using these drugs in patient groups with statin limitations arises. The purpose of the review. This article provides information on the use of PCSK9 inhibitors in the largest populations with limitations to statin therapy (patients with diabetes mellitus and patients with statin intolerance). We identified potentially relevant studies by searching the electronic databases MEDLINE, SCOPUS, PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews over the last 5 years up to March 2023 using the terms: dyslipidemia, hyperlipidemia, atherosclerosis, PCSK9 inhibitor, statins, low-density lipoproteins, cholesterol, efficacy, safety, therapy. Further, according to the inclusion and exclusion criteria, as well as independent selection, all authors of this article selected the sources that met the criteria and compiled this review. Results. PCSK9 inhibitors are generally a safe, well tolerated, and effective therapeutic strategy with an established role in the therapeutic treatment of hyperlipidemias. Theoretically, PCSK9 inhibitors can be used as an alternative to statin therapy for groups of patients with statin intolerance and those with diagnosed diabetes mellitus, as well as in risk groups. As the experience with using PCSK9 inhibitors in the Russian Federation is growing rapidly, future trials are expected to shed light on their long-term safety and tolerability. On the other hand, other potential therapeutic strategies targeting PCSK9 are being developed, including inclisiran, already registered in the Russian Federation, which is also promising in the treatment of lipid metabolism disorders.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124226422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The purpose of the review is to analyze Russian and foreign literature sources on safety of using omalizumab in the treatment of moderate to severe bronchial asthma and chronic idiopathic urticaria in children. Omalizumab is one of the longest used monoclonal antibodies and the first available treatment option for severe atopic asthma in patients aged 6 years and older. Its efficacy and safety have been established in several randomized controlled trials, leading to its final registration over 15 years ago. In most cases, long-term treatment with omalizumab is safe and does not increase the risk of adverse reactions. However, over the years, there has been a trend towards an increase in the number of registrations of adverse reactions associated with the use of omalizumab. Long-term adverse reactions with omalizumab therapy are not sufficiently studied and require more detailed analysis, despite reports of an association between omalizumab and some adverse events. There are very few reports of adverse reactions when taking omalizumab in children in the Russian Federation. Further study of the safety of omalizumab and monitoring of its delayed adverse reactions is required.
{"title":"Safety of omalizumab in children","authors":"K. O. Shnaider, M. Maksimov, B. Romanov","doi":"10.33920/med-03-2307-03","DOIUrl":"https://doi.org/10.33920/med-03-2307-03","url":null,"abstract":"The purpose of the review is to analyze Russian and foreign literature sources on safety of using omalizumab in the treatment of moderate to severe bronchial asthma and chronic idiopathic urticaria in children. Omalizumab is one of the longest used monoclonal antibodies and the first available treatment option for severe atopic asthma in patients aged 6 years and older. Its efficacy and safety have been established in several randomized controlled trials, leading to its final registration over 15 years ago. In most cases, long-term treatment with omalizumab is safe and does not increase the risk of adverse reactions. However, over the years, there has been a trend towards an increase in the number of registrations of adverse reactions associated with the use of omalizumab. Long-term adverse reactions with omalizumab therapy are not sufficiently studied and require more detailed analysis, despite reports of an association between omalizumab and some adverse events. There are very few reports of adverse reactions when taking omalizumab in children in the Russian Federation. Further study of the safety of omalizumab and monitoring of its delayed adverse reactions is required.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130645384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The paper describes the author-developed approach of the general practitioner Yu. I. Korshikova, who uses the method of assessing the patient's body type in the application of phytotherapy for the treatment of patients. Summary tables and basic principles for establishing the body type and approaches to the treatment of patients are presented.
{"title":"On expediency of assessing the patient’s body type in phytotherapy","authors":"Yuliya I. Korshikova","doi":"10.33920/med-03-2307-05","DOIUrl":"https://doi.org/10.33920/med-03-2307-05","url":null,"abstract":"The paper describes the author-developed approach of the general practitioner Yu. I. Korshikova, who uses the method of assessing the patient's body type in the application of phytotherapy for the treatment of patients. Summary tables and basic principles for establishing the body type and approaches to the treatment of patients are presented.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"93 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132282997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This article discusses an analytical approach to writing user and system requirements for the Nordic Walking Health Monitoring System and describes the tools which allow designing this web-based system.
{"title":"Health monitoring system for Nordic walking","authors":"O. Lebed, N. I. Kiseleva","doi":"10.33920/med-03-2307-04","DOIUrl":"https://doi.org/10.33920/med-03-2307-04","url":null,"abstract":"This article discusses an analytical approach to writing user and system requirements for the Nordic Walking Health Monitoring System and describes the tools which allow designing this web-based system.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"91 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133471745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：